DigitalOcean shares slide as investors digest recent upsized equity offering and added share supply

DigitalOcean Holdings, Inc. (DOCN) is down 5.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The most plausible driver is lingering dilution and supply concerns after DigitalOcean’s recently priced upsized public equity offering, which can pressure shares as the market absorbs new stock. This could also be amplified by routine profit-taking following a strong multi-month run in the name.

Details:

DigitalOcean priced an upsized underwritten public offering at about $800 million in gross proceeds, which increases the near-term supply of shares available to trade.

The offering included an underwriters’ option for additional shares, and that extra allotment was exercised in full, further increasing total shares sold.

Company materials described the raise as intended to support growth initiatives such as capacity expansion and balance-sheet actions, but equity financing can still weigh on the stock in the short run.

This could also reflect traders repositioning after the deal priced, as follow-on offerings frequently create an “overhang” until demand fully clears the new issuance.

Sources:

DigitalOcean Investor Relations, SEC EDGAR, Trefis

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$DOCN Insider Trading Activity

$DOCN insiders have traded $DOCN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $DOCN stock by insiders over the last 6 months:

CHERIE BARRETT (SVP, Chief Accounting Officer) sold 22,000 shares for an estimated $1,204,940
MATT STEINFORT (Chief Financial Officer) sold 20,000 shares for an estimated $1,108,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$DOCN Hedge Fund Activity

We have seen 201 institutional investors add shares of $DOCN stock to their portfolio, and 141 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS GROUP AG added 1,573,245 shares (+338.4%) to their portfolio in Q4 2025, for an estimated $75,704,549
BALYASNY ASSET MANAGEMENT L.P. removed 838,724 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $40,359,398
NORGES BANK removed 792,480 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $38,134,137
LAZARD ASSET MANAGEMENT LLC removed 776,966 shares (-50.4%) from their portfolio in Q4 2025, for an estimated $37,387,603
MARSHALL WACE, LLP removed 705,917 shares (-96.4%) from their portfolio in Q4 2025, for an estimated $33,968,726
ALYESKA INVESTMENT GROUP, L.P. removed 638,401 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $30,719,856
LMR PARTNERS LLP added 620,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $29,834,400

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$DOCN Analyst Ratings

Wall Street analysts have issued reports on $DOCN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

B of A Securities issued a "Buy" rating on 11/06/2025
Canaccord Genuity issued a "Buy" rating on 11/06/2025

To track analyst ratings and price targets for $DOCN, check out Quiver Quantitative's $DOCN forecast page.

$DOCN Price Targets

Multiple analysts have issued price targets for $DOCN recently. We have seen 10 analysts offer price targets for $DOCN in the last 6 months, with a median target of $79.0.

Here are some recent targets:

Patrick Walravens from Citizens set a target price of $105.0 on 03/26/2026
Timothy Horan from Oppenheimer set a target price of $100.0 on 03/18/2026
Wamsi Mohan from B of A Securities set a target price of $86.0 on 02/25/2026
Thomas Blakey from Cantor Fitzgerald set a target price of $83.0 on 02/25/2026
Raimo Lenschow from Barclays set a target price of $69.0 on 02/25/2026
Gabriela Borges from Goldman Sachs set a target price of $78.0 on 02/25/2026
Radi Sultan from UBS set a target price of $68.0 on 02/25/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.